Is SEEG safe? A systematic review and meta-analysis of stereo-electroencephalography-related complications.

Mullin JP, Shriver M, Alomar S, Najm I, Bulacio J, Chauvel P, et al. Is SEEG safe? A systematic review and meta-analysis of stereo-electroencephalography-related complications. Epilepsia. 2016;57(3):386-401. DOI: 10.1111/epi.13298. PubMed PMID: 26899389.

Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.

Strzelczyk A, Zschebek G, Bauer S, Baumgartner C, Grond M, Hermsen A, et al. Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians. Epilepsia. 2016;57(4):612-20. DOI: 10.1111/epi.13337. PubMed PMID: 26899504.

Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.

Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother. 1989;33(10):1704-8. PubMed PMID: 2556076.

Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.

Gataullina S, Lemaire E, Wendling F, Kaminska A, Watrin F, Riquet A, et al. Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex. Epilepsia. 2016;57(4):648-59. DOI: 10.1111/epi.13325. PubMed PMID: 26873267.

Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment.

Chen Z, Liew D, Kwan P. Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment. Neurology. 2016;86(12):1086-94. DOI: 10.1212/WNL.0000000000002484. PubMed PMID: 26888992.

Testing HLA-B*15:02: Is it worth it?

Marson A, Guerrini R. Testing HLA-B*15:02: Is it worth it?. Neurology. 2016;86(12):1080-1. DOI: 10.1212/WNL.0000000000002500. PubMed PMID: 26888996.

Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry.

Herzog AG, Mandle HB, Cahill KE, Fowler KM, Hauser WA, Davis AR. Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry. Epilepsia. 2016;57(4):630-7. DOI: 10.1111/epi.13320. PubMed PMID: 26880331.

Epilepsy in women during pregnancy.

Hehir MP, D'Alton ME. Epilepsy in women during pregnancy. Lancet. 2016;387(10019):645-6. DOI: 10.1016/S0140-6736(16)00283-X. PubMed PMID: 26876710.

Epilepsy in women during pregnancy.

Braillon A, Bewley S. Epilepsy in women during pregnancy. Lancet. 2016;387(10019):646. DOI: 10.1016/S0140-6736(16)00284-1. PubMed PMID: 26876712.

The safety of generic substitution in epilepsy.

Perucca E. The safety of generic substitution in epilepsy. Lancet Neurol. 2016;15(4):344-5. DOI: 10.1016/S1474-4422(16)00042-9. PubMed PMID: 26875742.